BusinessAccelerate Diagnostics Announces Closing of $79.3 Million Upsized OfferingBy Nasdaq OMXMay 15, 2017, 9:14 PM UTC
BusinessAccelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017By Nasdaq OMXMay 3, 2017, 8:08 PM UTC
BusinessAccelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017By Nasdaq OMXMay 3, 2017, 8:08 PM UTC
BusinessAccelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017By Nasdaq OMXMay 3, 2017, 8:08 PM UTC
BusinessAccelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017By Nasdaq OMXMay 3, 2017, 8:08 PM UTC
BusinessAccelerate Diagnostics Schedules Call to Review First Quarter 2017 Results for May 3rdBy Nasdaq OMXApr 18, 2017, 9:53 PM UTC
BusinessAccelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC KitBy Nasdaq OMXFeb 24, 2017, 2:46 AM UTC
BusinessGreat Basin Scientific Participates in CDC’s Get Smart About Antibiotics Week, Releases Antimicrobial Stewardship Survey FindingsBy Nasdaq OMXNov 17, 2016, 2:01 PM UTC
